Immuron Ltd Files 6-K Report
Ticker: IMRN · Form: 6-K · Filed: Jul 21, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Jul 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed a 6-K on 7/21/25, updating its status as a foreign private issuer.
AI Summary
Immuron Limited, a pharmaceutical company, filed a Form 6-K on July 21, 2025, reporting on its activities for the month of July 2025. The filing indicates the company is a foreign private issuer and is furnishing information under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The company is incorporated in Australia and its fiscal year ends on June 30.
Why It Matters
This filing provides an update on Immuron Limited's regulatory disclosures as a foreign private issuer, which is important for investors tracking the company's compliance and reporting activities.
Risk Assessment
Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- Immuron Limited (company) — Registrant
- 001-38104 (company) — SEC File Number
- July 2025 (date) — Reporting Period
- 20250721 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.
What is Immuron Limited's SEC file number?
Immuron Limited's SEC file number is 001-38104.
When does Immuron Limited's fiscal year end?
Immuron Limited's fiscal year ends on June 30.
Is Immuron Limited furnishing information under Rule 12g3-2(b)?
No, the filing indicates that Immuron Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the principal executive office address for Immuron Limited?
The principal executive office address for Immuron Limited is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 21, 2025 regarding Immuron Ltd (IMRN).